Table 1. Clinical data of men who underwent transrectal ultrasound guided prostate biopsy.
Variables | |
---|---|
Age* | 65.05±8.89 |
Total PSA (ng/ mL)* | 18.25±6.69 |
Free PSA (ng/ mL)* | 3.13±0.77 |
Prostate volume (cc)* | 60.27±29.96 |
Histopathology | |
BPH | 10 (45.5%) |
Chronic prostatitis | 2 (9.1%) |
ASAP | 1 (4.5%) |
High grade PIN | 2 (9.1%) |
Prostate adeno cancer | 7 |
Gleason score 3+3 | 3 (13.6%) |
Gleason score 3+4 | 1 (4.5%) |
Gleason score 4+5 | 1 (4.5%) |
Gleason score 5+4 | 2 (9.1%) |
Total (number of patients, %) | 22 (100%) |
SD = Standard deviation; PSA = Prostate-specific antigen; Ng/mL = nanogram per mililiter; cc = cubic centimeter; BPH = Benign prostatic hyperplasia; ASAP = Atypical small acinar proliferation; PIN = prostatic intraepithelial neoplasia; *mean±SD